Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized GM-CSF in metastatic renal cell carcinoma
NCT00006483Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2000
- Primary completion
- Jan 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of sargramostim in renal cell carcinoma (RCC), sponsored by Cancer and Leukemia Group B. Started Oct 2000; status: completed.
02
Drugs
sargramostim
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00006483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006483.